Association between metformin (M) use and survival among non-small cell lung cancer (NSCLC) patients (pts).
Publication
, Conference
Fortune-Greeley, AK; Williams, CD; Paulus, JK; Kelley, MJ
Published in: Journal of Clinical Oncology
May 20, 2014
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2014
Volume
32
Issue
15_suppl
Start / End Page
7568 / 7568
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Fortune-Greeley, A. K., Williams, C. D., Paulus, J. K., & Kelley, M. J. (2014). Association between metformin (M) use and survival among non-small cell lung cancer (NSCLC) patients (pts). In Journal of Clinical Oncology (Vol. 32, pp. 7568–7568). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.7568
Fortune-Greeley, Alice K., Christina D. Williams, Jessica K. Paulus, and Michael J. Kelley. “Association between metformin (M) use and survival among non-small cell lung cancer (NSCLC) patients (pts).” In Journal of Clinical Oncology, 32:7568–7568. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.7568.
Fortune-Greeley AK, Williams CD, Paulus JK, Kelley MJ. Association between metformin (M) use and survival among non-small cell lung cancer (NSCLC) patients (pts). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 7568–7568.
Fortune-Greeley, Alice K., et al. “Association between metformin (M) use and survival among non-small cell lung cancer (NSCLC) patients (pts).” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 7568–7568. Crossref, doi:10.1200/jco.2014.32.15_suppl.7568.
Fortune-Greeley AK, Williams CD, Paulus JK, Kelley MJ. Association between metformin (M) use and survival among non-small cell lung cancer (NSCLC) patients (pts). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 7568–7568.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2014
Volume
32
Issue
15_suppl
Start / End Page
7568 / 7568
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences